US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist
  • 1.380
  • +0.020+1.47%
Close Dec 26 16:00 ET
41.23MMarket Cap-0.69P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-35.25%11.77M
-4.34%15.88M
14.07%18.3M
64.77%69.64M
50.81%18.82M
54.46%18.18M
60.66%16.6M
108.76%16.04M
95.89%42.26M
64.29%12.48M
Selling and administrative expenses
-7.12%3.48M
21.81%3.73M
-10.19%3.64M
15.79%14.76M
4.62%3.9M
12.24%3.75M
-15.74%3.06M
97.76%4.05M
173.16%12.75M
108.98%3.72M
-General and administrative expense
-7.12%3.48M
21.81%3.73M
-10.19%3.64M
15.79%14.76M
4.62%3.9M
12.24%3.75M
-15.74%3.06M
97.76%4.05M
173.16%12.75M
108.98%3.72M
Research and development costs
-42.57%8.29M
-10.26%12.15M
22.28%14.66M
85.93%54.87M
70.46%14.92M
71.20%14.43M
102.12%13.54M
112.76%11.99M
74.56%29.51M
50.58%8.75M
Operating profit
35.25%-11.77M
4.34%-15.88M
-14.07%-18.3M
-64.77%-69.64M
-50.81%-18.82M
-54.46%-18.18M
-60.66%-16.6M
-108.76%-16.04M
-95.89%-42.26M
-64.29%-12.48M
Net non-operating interest income expense
Other net income (expense)
-166.26%-976K
81.30%1.45M
134.50%1.68M
275.42%4.9M
202.37%1.92M
241.76%1.47M
274.18%797K
2,457.14%716K
3,536.84%1.31M
2,781.82%634K
Special income (charges)
---2.24M
----
----
----
----
--0
----
----
----
----
-Less：Restructuring and merger&acquisition
--2.24M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-13.99%1.27M
81.30%1.45M
134.50%1.68M
275.42%4.9M
202.37%1.92M
241.76%1.47M
274.18%797K
2,457.14%716K
3,536.84%1.31M
2,781.82%634K
Income before tax
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
Income tax
Net income
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
Net income continuous Operations
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
Minority interest income
Net income attributable to the parent company
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-58.05%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-100.17%-15.32M
-90.11%-40.96M
-56.95%-11.84M
Preferred stock dividends
-72.06%1.82M
0
Other preferred stock dividends
Net income attributable to common stockholders
23.70%-12.75M
8.66%-14.44M
-8.44%-16.62M
-51.33%-64.73M
-42.70%-16.9M
-47.34%-16.71M
-56.17%-15.8M
-61.72%-15.32M
-52.46%-42.78M
-25.05%-11.84M
Basic earnings per share
33.85%-0.43
40.74%-0.48
29.11%-0.56
1.79%-2.74
6.56%-0.57
-10.17%-0.65
-55.30%-0.81
73.49%-0.79
-80.38%-2.79
-16.85%-0.61
Diluted earnings per share
33.85%-0.43
40.74%-0.48
29.11%-0.56
1.79%-2.74
6.56%-0.57
-10.17%-0.65
-55.30%-0.81
73.49%-0.79
-80.38%-2.79
-16.85%-0.61
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -35.25%11.77M-4.34%15.88M14.07%18.3M64.77%69.64M50.81%18.82M54.46%18.18M60.66%16.6M108.76%16.04M95.89%42.26M64.29%12.48M
Selling and administrative expenses -7.12%3.48M21.81%3.73M-10.19%3.64M15.79%14.76M4.62%3.9M12.24%3.75M-15.74%3.06M97.76%4.05M173.16%12.75M108.98%3.72M
-General and administrative expense -7.12%3.48M21.81%3.73M-10.19%3.64M15.79%14.76M4.62%3.9M12.24%3.75M-15.74%3.06M97.76%4.05M173.16%12.75M108.98%3.72M
Research and development costs -42.57%8.29M-10.26%12.15M22.28%14.66M85.93%54.87M70.46%14.92M71.20%14.43M102.12%13.54M112.76%11.99M74.56%29.51M50.58%8.75M
Operating profit 35.25%-11.77M4.34%-15.88M-14.07%-18.3M-64.77%-69.64M-50.81%-18.82M-54.46%-18.18M-60.66%-16.6M-108.76%-16.04M-95.89%-42.26M-64.29%-12.48M
Net non-operating interest income expense
Other net income (expense) -166.26%-976K81.30%1.45M134.50%1.68M275.42%4.9M202.37%1.92M241.76%1.47M274.18%797K2,457.14%716K3,536.84%1.31M2,781.82%634K
Special income (charges) ---2.24M------------------0----------------
-Less：Restructuring and merger&acquisition --2.24M------------------0----------------
Other non- operating income (expenses) -13.99%1.27M81.30%1.45M134.50%1.68M275.42%4.9M202.37%1.92M241.76%1.47M274.18%797K2,457.14%716K3,536.84%1.31M2,781.82%634K
Income before tax 23.70%-12.75M8.66%-14.44M-8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M
Income tax
Net income 23.70%-12.75M8.66%-14.44M-8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M
Net income continuous Operations 23.70%-12.75M8.66%-14.44M-8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M
Minority interest income
Net income attributable to the parent company 23.70%-12.75M8.66%-14.44M-8.44%-16.62M-58.05%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-100.17%-15.32M-90.11%-40.96M-56.95%-11.84M
Preferred stock dividends -72.06%1.82M0
Other preferred stock dividends
Net income attributable to common stockholders 23.70%-12.75M8.66%-14.44M-8.44%-16.62M-51.33%-64.73M-42.70%-16.9M-47.34%-16.71M-56.17%-15.8M-61.72%-15.32M-52.46%-42.78M-25.05%-11.84M
Basic earnings per share 33.85%-0.4340.74%-0.4829.11%-0.561.79%-2.746.56%-0.57-10.17%-0.65-55.30%-0.8173.49%-0.79-80.38%-2.79-16.85%-0.61
Diluted earnings per share 33.85%-0.4340.74%-0.4829.11%-0.561.79%-2.746.56%-0.57-10.17%-0.65-55.30%-0.8173.49%-0.79-80.38%-2.79-16.85%-0.61
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
SilverCrest Metals
SILV
+2.40%
Cars.com
CARS
+2.25%
Lantheus
LNTH
+2.14%
Collegium Pharmaceutical
COLL
+1.48%
Hutchmed (China)
HCM
+1.19%

Unlock the Full List